An isolated nucleic acid comprising a nucleotide sequence at least 70% identical to SEQ ID NO:1, or a complementary sequence thereof. Presence of the nucleic acid in a subject predisposes the subject to an abnormal liver condition, an adenocarcinoma, or a combination thereof. Also disclosed are a method of diagnosing such diseases, a method of identifying a compound for treating such diseases, and a method of treating such diseases.